Cidara Therapeutics is developing innovative therapies to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Our initial focus is on devastating fungal infections that often complicate cancer and transplant treatments. Such infections can lead to mortality rates exceeding 50%.